[{"id":"279f72d7-b141-456e-a82c-b2efb50e3de3","acronym":"BT7480-100","url":"https://clinicaltrials.gov/study/NCT05163041","created_at":"2021-12-20T16:53:57.547Z","updated_at":"2025-02-25T16:53:58.735Z","phase":"Phase 1/2","brief_title":"Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression","source_id_and_acronym":"NCT05163041 - BT7480-100","lead_sponsor":"BicycleTx Limited","biomarkers":" NECTIN4","pipe":" | ","alterations":" NECTIN4 expression","tags":["NECTIN4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NECTIN4 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • BT7480"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 11/02/2021","start_date":" 11/02/2021","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2025-02-04"}]